Martin Shkreli fails to overturn lifetime pharma ban — again; Daiichi Sankyo and ViGeneron re-up eye disease deal
Martin Shkreli has once again been unable to convince a judge to overturn his lifetime pharma industry ban.
Shkreli had attempted to put the ban …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
